121 related articles for article (PubMed ID: 11892214)
41. Apomorphine effects on brain metabolism in neuroleptic-naive schizophrenic patients.
Cleghorn JM; Szechtman H; Garnett ES; Nahmias C; Brown GM; Kaplan RD; Szechtman B; Franco S
Psychiatry Res; 1991 Oct; 40(2):135-53. PubMed ID: 1763143
[TBL] [Abstract][Full Text] [Related]
42. Contribution of PET studies in diagnosis of corticobasal degeneration.
Lutte I; Laterre C; Bodart JM; De Volder A
Eur Neurol; 2000; 44(1):12-21. PubMed ID: 10894990
[TBL] [Abstract][Full Text] [Related]
43. Neuroimaging in infantile autism.
Schifter T; Hoffman JM; Hatten HP; Hanson MW; Coleman RE; DeLong GR
J Child Neurol; 1994 Apr; 9(2):155-61. PubMed ID: 8006366
[TBL] [Abstract][Full Text] [Related]
44. Cortical activation in profoundly deaf patients during cochlear implant stimulation demonstrated by H2(15)O PET.
Herzog H; Lamprecht A; Kühn A; Roden W; Vosteen KH; Feinendegen LE
J Comput Assist Tomogr; 1991; 15(3):369-75. PubMed ID: 1851187
[TBL] [Abstract][Full Text] [Related]
45. The effect of anxiety and hostility in silent mentation on localized cerebral glucose metabolism.
Gottschalk LA; Buchsbaum MS; Gillin JC; Wu J; Reynolds CA; Herrera DB
Compr Psychiatry; 1992; 33(1):52-9. PubMed ID: 1555410
[TBL] [Abstract][Full Text] [Related]
46. Brain metabolism of children with profound deafness: a visual language activation study by 18F-fluorodeoxyglucose positron emission tomography.
Fujiwara K; Naito Y; Senda M; Mori T; Manabe T; Shinohara S; Kikuchi M; Hori SY; Tona Y; Yamazaki H
Acta Otolaryngol; 2008 Apr; 128(4):393-7. PubMed ID: 18368572
[TBL] [Abstract][Full Text] [Related]
47. Transient focal cortical hypometabolism in idiopathic West syndrome.
Maeda N; Watanabe K; Negoro T; Aso K; Haga Y; Kito M; Ohki T; Ito K; Kato T
Pediatr Neurol; 1993; 9(6):430-4. PubMed ID: 7605550
[TBL] [Abstract][Full Text] [Related]
48. Functional brain imaging of a catatonic type of schizophrenia: PET and SPECT studies.
Satoh K; Narita M; Someya T; Fukuyama H; Yonekura Y
Jpn J Psychiatry Neurol; 1993 Dec; 47(4):881-5. PubMed ID: 8201798
[TBL] [Abstract][Full Text] [Related]
49. Reduced regional cerebral metabolic rate for glucose at the terminal stage in a case of late infantile neuronal ceroid lipofuscinosis.
Fueki N; Iinuma K; Kojima A; Yanai K; Haginoya K; Tada K; Ido T; Ito M
J Child Neurol; 1990 Apr; 5(2):98-100. PubMed ID: 2345285
[TBL] [Abstract][Full Text] [Related]
50. Regional cerebral glucose utilization in chronic organic mental disorders associated with alcoholism.
Martin PR; Rio D; Adinoff B; Johnson JL; Bisserbe JC; Rawlings RR; Rohrbaugh JW; Stapleton JM; Eckardt MJ
J Neuropsychiatry Clin Neurosci; 1992; 4(2):159-67. PubMed ID: 1627977
[TBL] [Abstract][Full Text] [Related]
51. Tomographic mapping of human cerebral metabolism: sensory deprivation.
Mazziotta JC; Phelps ME; Carson RE; Kuhl DE
Ann Neurol; 1982 Nov; 12(5):435-44. PubMed ID: 6983853
[TBL] [Abstract][Full Text] [Related]
52. Effects of high amphetamine dose on mood and cerebral glucose metabolism in normal volunteers using positron emission tomography (PET).
Vollenweider FX; Maguire RP; Leenders KL; Mathys K; Angst J
Psychiatry Res; 1998 Sep; 83(3):149-62. PubMed ID: 9849724
[TBL] [Abstract][Full Text] [Related]
53. Cortical metabolism in posterolateral thalamic stroke: PET study.
Chabriat H; Pappata S; Levasseur M; Fiorelli M; Tran Dinh S; Baron JC
Acta Neurol Scand; 1992 Sep; 86(3):285-90. PubMed ID: 1414249
[TBL] [Abstract][Full Text] [Related]
54. Functional cortical deafferentation from the subcortical structures in a patient with early myoclonic encephalopathy: a functional neuroimaging study.
Hirose M; Haginoya K; Yokoyama H; Tanaka S; Uematsu M; Kaneta T; Takayanagi M; Kon K; Yoshihara Y; Iinuma K; Tsuchiya S
Epilepsia; 2010 Apr; 51(4):699-702. PubMed ID: 19922588
[TBL] [Abstract][Full Text] [Related]
55. Atypical white-matter microstructure in congenitally deaf adults: A region of interest and tractography study using diffusion-tensor imaging.
Karns CM; Stevens C; Dow MW; Schorr EM; Neville HJ
Hear Res; 2017 Jan; 343():72-82. PubMed ID: 27473505
[TBL] [Abstract][Full Text] [Related]
56. The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease.
Sultzer DL; Mahler ME; Mandelkern MA; Cummings JL; Van Gorp WG; Hinkin CH; Berisford MA
J Neuropsychiatry Clin Neurosci; 1995; 7(4):476-84. PubMed ID: 8555751
[TBL] [Abstract][Full Text] [Related]
57. Effect of sertraline on regional metabolic rate in patients with affective disorder.
Buchsbaum MS; Wu J; Siegel BV; Hackett E; Trenary M; Abel L; Reynolds C
Biol Psychiatry; 1997 Jan; 41(1):15-22. PubMed ID: 8988791
[TBL] [Abstract][Full Text] [Related]
58. Hypnotic catalepsy-induced changes of regional cerebral glucose metabolism.
Grond M; Pawlik G; Walter H; Lesch OM; Heiss WD
Psychiatry Res; 1995 Sep; 61(3):173-9. PubMed ID: 8545501
[TBL] [Abstract][Full Text] [Related]
59. PET in relation to intracranial electrode evaluations.
Engel J; Henry TR; Risinger MW; Sutherling WW; Chugani HT
Epilepsy Res Suppl; 1992; 5():111-20. PubMed ID: 1418439
[No Abstract] [Full Text] [Related]
60. Is epileptogenic cortex truly hypometabolic on interictal positron emission tomography?
Juhász C; Chugani DC; Muzik O; Watson C; Shah J; Shah A; Chugani HT
Ann Neurol; 2000 Jul; 48(1):88-96. PubMed ID: 10894220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
